Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adnan Kastrati

Showing results (1-10 of 937) with videos related to

Pageof 94
Sort By:
Thrombosis Research|October 3, 2012
New anti-platelet agents: the end of resistance?Adnan Kastrati
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|February 18, 2010
Is diabetes a leveler of efficacy of DES types?Adnan Kastrati
The New England Journal of Medicine|March 30, 2026
IVUS - A Zigzag Path to SuccessAdnan Kastrati
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|February 22, 2008
Drug for a while, polymer for life: Is it a good solution?Adnan Kastrati
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|October 27, 2004
Drug-eluting stents for secondary prevention of restenosisAdnan Kastrati
JAMA|September 1, 2011
Need for critical reappraisal of intra-aortic balloon counterpulsationGjin Ndrepepa, Adnan Kastrati
Lancet (London, England)|September 4, 2009
Risk of combining PPIs with thienopyridines: fact or fiction?Dirk Sibbing, Adnan Kastrati
European Heart Journal|June 19, 2015
Genetic testing to guide therapy? Not for ticagrelor!Christian Hengstenberg, Adnan Kastrati
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|January 21, 2017
Don't think twice: BMS is never niceRoisin Colleran, Adnan Kastrati
Journal of the American Heart Association|March 4, 2020
Long-Term Ticagrelor Versus Prasugrel Pharmacodynamics in Patients With ST-Segment-Elevation Myocardial InfarctionSalvatore Cassese, Adnan Kastrati
Pageof 94

Showing results (1-10 of 937) with videos related to

Sort By:
Pageof 94
Thrombosis Research|October 3, 2012
New anti-platelet agents: the end of resistance?Adnan Kastrati
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|February 18, 2010
Is diabetes a leveler of efficacy of DES types?Adnan Kastrati
The New England Journal of Medicine|March 30, 2026
IVUS - A Zigzag Path to SuccessAdnan Kastrati
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|February 22, 2008
Drug for a while, polymer for life: Is it a good solution?Adnan Kastrati
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|October 27, 2004
Drug-eluting stents for secondary prevention of restenosisAdnan Kastrati
JAMA|September 1, 2011
Need for critical reappraisal of intra-aortic balloon counterpulsationGjin Ndrepepa, Adnan Kastrati
Lancet (London, England)|September 4, 2009
Risk of combining PPIs with thienopyridines: fact or fiction?Dirk Sibbing, Adnan Kastrati
European Heart Journal|June 19, 2015
Genetic testing to guide therapy? Not for ticagrelor!Christian Hengstenberg, Adnan Kastrati
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|January 21, 2017
Don't think twice: BMS is never niceRoisin Colleran, Adnan Kastrati
Journal of the American Heart Association|March 4, 2020
Long-Term Ticagrelor Versus Prasugrel Pharmacodynamics in Patients With ST-Segment-Elevation Myocardial InfarctionSalvatore Cassese, Adnan Kastrati
Pageof 94